Malarkey DE - Search Results

1

Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors.

Maronpot RR, Fox T, Malarkey DE, Goldsworthy TL. Maronpot RR, et al. Among authors: malarkey de. Toxicology. 1995 Aug 25;101(3):125-56. doi: 10.1016/0300-483x(95)03112-s. Toxicology. 1995. PMID: 7676462 Review.

2

Identification of spontaneous feline idiopathic pulmonary fibrosis: morphology and ultrastructural evidence for a type II pneumocyte defect.

Williams K, Malarkey D, Cohn L, Patrick D, Dye J, Toews G. Williams K, et al. Chest. 2004 Jun;125(6):2278-88. doi: 10.1378/chest.125.6.2278. Chest. 2004. PMID: 15189952

3

Hepatocarcinogenicity of chlordane in B6C3F1 and B6D2F1 male mice: evidence for regression in B6C3F1 mice and carcinogenesis independent of ras proto-oncogene activation.

Malarkey DE, Devereux TR, Dinse GE, Mann PC, Maronpot RR. Malarkey DE, et al. Carcinogenesis. 1995 Nov;16(11):2617-25. doi: 10.1093/carcin/16.11.2617. Carcinogenesis. 1995. PMID: 7586176

4

H-ras oncogene mutation spectra in B6C3F1 and C57BL/6 mouse liver tumors provide evidence for TCDD promotion of spontaneous and vinyl carbamate-initiated liver cells.

Watson MA, Devereux TR, Malarkey DE, Anderson MW, Maronpot RR. Watson MA, et al. Among authors: malarkey de. Carcinogenesis. 1995 Aug;16(8):1705-10. doi: 10.1093/carcin/16.8.1705. Carcinogenesis. 1995. PMID: 7634393

5

ras proto-oncogene activation in dichloroacetic acid-, trichloroethylene- and tetrachloroethylene-induced liver tumors in B6C3F1 mice.

Anna CH, Maronpot RR, Pereira MA, Foley JF, Malarkey DE, Anderson MW. Anna CH, et al. Among authors: malarkey de. Carcinogenesis. 1994 Oct;15(10):2255-61. doi: 10.1093/carcin/15.10.2255. Carcinogenesis. 1994. PMID: 7955063

6

Polymerase chain reaction and in situ hybridization: applications in toxicological pathology.

Malarkey DE, Maronpot RR. Malarkey DE, et al. Toxicol Pathol. 1996 Jan-Feb;24(1):13-23. doi: 10.1177/019262339602400104. Toxicol Pathol. 1996. PMID: 8839277 Review.

7

Spontaneous and chemically induced proliferative lesions in Tg.AC transgenic and p53-heterozygous mice.

Mahler JF, Flagler ND, Malarkey DE, Mann PC, Haseman JK, Eastin W. Mahler JF, et al. Among authors: malarkey de. Toxicol Pathol. 1998 Jul-Aug;26(4):501-11. doi: 10.1177/019262339802600406. Toxicol Pathol. 1998. PMID: 9715509

8

Impact of Helicobacter hepaticus infection in B6C3F1 mice from twelve National Toxicology Program two-year carcinogenesis studies.

Hailey JR, Haseman JK, Bucher JR, Radovsky AE, Malarkey DE, Miller RT, Nyska A, Maronpot RR. Hailey JR, et al. Among authors: malarkey de. Toxicol Pathol. 1998 Sep-Oct;26(5):602-11. doi: 10.1177/019262339802600503. Toxicol Pathol. 1998. PMID: 9789946

9

Altered bcl-2 family expression during non-genotoxic hepatocarcinogenesis in mice.

Christensen JG, Romach EH, Healy LN, Gonzales AJ, Anderson SP, Malarkey DE, Corton JC, Fox TR, Cattley RC, Goldsworthy TL. Christensen JG, et al. Among authors: malarkey de. Carcinogenesis. 1999 Aug;20(8):1583-90. doi: 10.1093/carcin/20.8.1583. Carcinogenesis. 1999. PMID: 10426811

10

The hepatic endothelial carcinogen riddelliine induces endothelial apoptosis, mitosis, S phase, and p53 and hepatocytic vascular endothelial growth factor expression after short-term exposure.

Nyska A, Moomaw CR, Foley JF, Maronpot RR, Malarkey DE, Cummings CA, Peddada S, Moyer CF, Allen DG, Travlos G, Chan PC. Nyska A, et al. Among authors: malarkey de. Toxicol Appl Pharmacol. 2002 Nov 1;184(3):153-64. doi: 10.1006/taap.2002.9485. Toxicol Appl Pharmacol. 2002. PMID: 12460743

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters